Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Mushroom Poisoning, Emergency Medicine


Basics


Description


  • Amanitin/phalloidin:
    • Species:
      • Amanita phalloides ( "death cap " )
      • Amanita virosa/Amanita verna ( "destroying angel " )
      • Galerina marginata, Galerina venenata
    • Mechanism:
      • Cyclopeptide toxins inhibit RNA polymerase 2, which kills GI epithelium, hepatocytes, nephrocytes
  • Gyromitrin:
    • Species:
      • Gyromitra esculenta ( "false morels " )
      • Other Gyromitra spp.
    • Mechanism:
      • Inhibits pyridoxal phosphate
      • Damage to RBCs, hepatocytes, neurons
  • Muscarine:
    • Species:
      • Inocybe (several species)
      • Clitocybe (several species)
    • Mechanism:
      • Parasympathomimetic
  • Coprine:
    • Species:
      • Coprinus atramentarius ( "inky caps " )
    • Mechanism:
      • Blocks acetaldehyde dehydrogenase
      • Causes disulfiram-like reaction if mixed with alcohol
  • Ibotenic acid/muscimol:
    • Species:
      • Amanita pantherina ( "the panther " )
      • Amanita muscaria ( "fly agaric " )
    • Mechanism:
      • GABA agonists
  • Psilocin/psilocybin:
    • Species:
      • Psilocybe and Panaeolus spp. as well as others
    • Mechanism:
      • Similar structure to lysergic acid diethylamide, effect serotonin receptor
  • Gastric irritants:
    • Many various mushrooms, including those normally considered edible
  • Orellanine:
    • Species:
      • Cortinarius (several species)
    • Mechanism:
      • Direct renal toxicity
  • Tricholoma equestre ( "man on horse " ):
    • Rhabdomyolysis-inducing mushrooms
    • Unidentified myotoxin

Diagnosis


Signs and Symptoms


  • Amanitin/phalloidin:
    • Nausea
    • Vomiting
    • Abdominal cramps
    • Bloody diarrhea
    • Clinical course:
      • Onset of symptoms delayed 6 " “36 hr with development of GI symptoms
      • Transient latent phase may last 2 days (no pain/symptoms)
      • Can progress to hepatic or renal failure and death in 2 " “6 days
      • Most lethal mushroom toxins
  • Gyromitrin:
    • 1st 5 " “10 hr:
      • Abdominal cramps
      • Nausea/vomiting
      • Watery diarrhea
    • Later symptoms:
      • Weakness
      • Cyanosis
      • Confusion
      • Seizures
      • Coma
  • Muscarine:
    • Cholinergic symptoms include:
      • Miosis
      • Salivation
      • Lacrimation
      • Sweating
      • Diarrhea
      • Flushed skin
      • Nausea
      • Bradycardia
      • Bronchoconstriction
    • Onset usually within 1 hr (may be delayed)
  • Coprine:
    • Disulfiram-like reaction within minutes to hours when combined with alcohol:
      • Flushing
      • Sweating
      • Nausea/vomiting
      • Palpitations
  • Ibotenic acid/muscimol:
    • Relatively rapid onset of 30 " “120 min
    • GABA agonist effects include:
      • Hallucinations
      • Dysarthria
      • Ataxia
      • Somnolence/coma
    • Glutamatergic effects (mainly pediatrics):
      • Seizures
      • Muscle cramps/myoclonic movements
  • Psilocin/psilocybin:
    • Rapid onset, usually resolves in 6 " “12 hr
    • Visual hallucinations
    • Alteration of perception
    • Mydriasis
    • Tachycardia
    • Fever and seizures in children
  • Gastric irritants:
    • Group of toxins that cause nausea, vomiting, intestinal cramps, and watery diarrhea
    • Onset 30 min to 3 hr, usually resolved in 6 " “12 hr
  • Orellanine/Amanita smithiana:
    • Nausea/vomiting
    • Headache
    • Sweating
    • Chills
    • Low-back pain
    • Polydipsia
    • Clinical course:
      • May progress to oliguria and acute renal failure
      • Markedly delayed onset of symptoms (2 " “14 days)
  • T. equestre:
    • Acute rhabdomyolysis:
      • Myalgias/arthralgias
      • Hematuria/dark urine
      • Decreased urine output
    • Dehydration

History
  • Time of ingestion
  • Time of symptom onset
  • Quantity ingested
  • Preparation: Raw or cooked
  • Picked in the wild or store-bought
  • Coingestants, other mushrooms
  • Alcohol/drug use history
  • Symptoms of family members, friends

Physical Exam
  • Vital signs
  • Changes in mental status
  • Pupillary response
  • Cardiopulmonary exam
  • Abdominal exam
  • Neurologic exam

Essential Workup


  • Mushroom description:
    • Pileus (cap); margin shape
    • Stipe (stem)
    • Lamellae (gills)
    • Veil
    • Annulus (ring)
    • Volva
  • Store mushroom in brown paper bag for future identification:
    • <3% of cases result in an exact mushroom identification.
    • Digital photography and electronic image transfer to poison control center or regional mycologist

Diagnosis Tests & Interpretation


Lab
  • CBC
  • Prothrombin time (PT), partial thromboplastin time (PTT)
  • Electrolytes, BUN, creatinine, glucose
  • Urinalysis
  • LFTs, creatine phosphokinase (CPK)
  • Imaging
  • Spore print: Mycologist needed for specific genus/species interpretation

Differential Diagnosis


  • Very broad differential
  • Gastroenteritis
  • Hepatitis/acetaminophen hepatotoxicity
  • Acute renal failure (many causes)
  • Rhabdomyolysis (many causes)
  • Cholinergic syndrome (e.g., organophosphates)
  • Anticholinergic syndrome
  • Seizures (many causes)

Treatment


Pre-Hospital


Bring any unconsumed mushrooms or mushroom pieces to hospital to aid in diagnosis: ‚  
  • Refrigerate specimens if possible, place in brown paper bag.

Initial Stabilization/Therapy


  • ABCs
  • Establish IV 0.9% NS saline
  • Monitor
  • Naloxone, D50W (or Accu-Chek), and thiamine for altered mental status

Ed Treatment/Procedures


General Measures
  • Decontamination:
    • Activated charcoal (50 " “100 g)
    • Gastric decontamination if early after ingestion and patient:
      • Has not yet vomited.
      • Has normal mental and respiratory status
      • Is not undergoing hallucinations
  • Fluid rehydration and electrolyte replacement as necessary
  • Call local poison control center at 800-222-1222 and request mycologist " ”digital picture may be electronically sent for identification.
  • Obtain specimens (vomitus if needed) for identification.

Mushroom-specific Therapy
  • Amanitin/phalloidin:
    • Administer activated charcoal PO q2 " “4h.
    • Hypoglycemia and elevated PT:
      • Signs of liver failure
      • Administer fresh-frozen plasma and vitamin K for coagulation disorders with active bleeding.
    • Administer calcium in presence of hypocalcemia.
    • Liver transplant for severe hepatic necrosis
    • Consider N-acetylcysteine, high-dose penicillin G, or silibinin if available (thioctic acid controversial)
  • Gyromitrin:
    • Treat seizure with benzodiazepines.
      • Administer pyridoxine (vitamin B6) in severely symptomatic patients.
    • Treat liver dysfunctions as outlined for amanitin/phalloidin group.
    • Dialysis for renal failure
  • Muscarine:
    • Administer atropine in severe cases.
  • Coprine:
    • Self-limited toxicity " ”supportive care
    • Avoid syrup of ipecac (contains alcohol)
    • Ž ²-Blockers for cardiac dysrhythmias
  • Ibotenic acid/muscimol:
    • Usually self-limited toxicity
    • Provide supportive care
    • Monitor for hypotension
    • Treat moderate symptoms with benzodiazepines, if severe anticholinergic symptoms; consider physostigmine.
  • Psilocin/psilocybin:
    • Self-limited toxicity
    • Dark, quiet room and reassurance
    • Benzodiazepines for agitation
    • External cooling measures if needed in children
  • GI Irritants:
    • When poisoning from above groups not suspected, administer fluids and antiemetics.
    • Provide supportive care
  • Orellanine and A. smithiana:
    • Closely monitor BUN, creatinine, electrolytes, and urine output.
    • Forced diuresis with Lasix contraindicated
    • Diuresis with alkalinization of urine with NaHCO3 if signs of rhabdomyolysis
    • Hemodialysis/renal transplantation may be needed.
  • T. equestre ( "man on horse " ):
    • Fluid hydration
    • Check and follow CPK.
    • Monitor urine output.

Medication


  • Activated charcoal slurry: 1 " “2 g/kg up to 100 g PO
  • Atropine: 0.5 mg (peds: 0.02 mg/kg) IV; repeat 0.5 " “1 mg IV (peds: 0.04 mg/kg) q10min if secretions recur, to max. 1 mg/kg in children and 2 mg/kg in adults
  • Dextrose: D50W 1 amp: 50 mL or 25 g (peds: D25W 2 " “4 mL/kg) IV
  • Diazepam (benzodiazepine): 5 " “10 mg (peds: 0.2 " “0.5 mg/kg) IV
  • Lorazepam (benzodiazepine): 2 " “6 mg (peds: 0.03 " “0.05 mg/kg) IV
  • Naloxone (Narcan): 2 mg (peds: 0.1 mg/kg) IV or IM initial dose
  • Physostigmine: 0.5 " “2 mg IM or IV in adults
  • Propranolol: 1 mg (peds: 0.01 " “0.1 mg/kg) IV
  • Pyridoxine: 25 mg/kg IV over 30 min
  • Thiamine (vitamin B1): 100 mg (peds: 50 mg) IV or IM

Follow-Up


Disposition


Admission Criteria
  • All symptomatic patients:
    • Protracted vomiting, dehydration, liver or renal toxicity, or seizures
  • Transfer to tertiary medical center for early signs of renal or hepatic failure.
  • Symptomatic infants and young children found with mushrooms:
    • Assume ingestion.
  • ICU admission for known ingestion of an amanitin-containing mushroom:
    • Early liver service consultation

Discharge Criteria
Asymptomatic during 6 " “8 hr with 24 hr of close home observation and close follow-up (if reliable caregivers) ‚  
Issues for Referral
Potential liver or renal transplantation ‚  

Followup Recommendations


Drug detoxification programs if chronic recreational use ‚  

Pearls and Pitfalls


  • There are old mushroom pickers, and bold mushroom pickers; but there are no old, bold mushroom pickers.
  • Symptoms with late onset (>6 hr) generally indicate more lethal toxins.
  • Lack of proper mycologic identification
  • Timely organ transplant referrals when indicated

Additional Reading


  • Beuhler ‚  MC, Sasser ‚  HC, Watson ‚  WA. The outcome of North American pediatric unintentional mushroom ingestions with various decontamination treatments: An analysis of 14 years of TESS data. Toxicon.  2009;53(4):437 " “443.
  • Diaz ‚  JH. Syndromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med.  2005;33(2):427 " “436.
  • Goldfrank ‚  LR. Mushrooms In: Goldfrank ‚  LR, ed. Goldfranks Toxicologic Emergencies. 9th ed. New York, NY: McGraw-Hill, 2011:1522 " “1536.
  • Matsuura ‚  M, Saikawa ‚  Y, Inui ‚  K, et al. Identification of the toxic trigger in mushroom poisoning. Nat Chem Biol.  2009;5(7):465 " “467.
  • West ‚  PL, Lindgren ‚  J, Horowitz ‚  BZ. Amanita smithiana mushroom ingestion: A case of delayed renal failure and literature review. J Med Toxicol.  2009;5(1):32 " “38.

Codes


ICD9


988.1 Toxic effect of mushrooms eaten as food ‚  

ICD10


T62.0X1A Toxic effect of ingested mushrooms, accidental, init ‚  

SNOMED


  • 86505009 Toxic effect from eating mushrooms (disorder)
  • 216771005 Accidental poisoning from mushrooms (disorder)
  • 242358002 Accidental ingestion of hallucinogenic mushrooms (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer